| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:864.)
© 2009 American Heart Association, Inc.
Original Contributions |
From the Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Canada.
Correspondence to Patricia Manns, 2-50 Corbett Hall, Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta, T6G 2G4. E-mail trish.manns{at}ualberta.ca
| Abstract |
|---|
|
|
|---|
Methods— Ten subacute stroke survivors participated (mean±SD; age: 66±15 years; time from stroke to discharge: 75±31 days). Data collection was completed across three time periods, predischarge, 2 weeks postdischarge, and 6 weeks postdischarge. The Step Activity Monitor (Cyma Corporation) was used to measure daily activity parameters. Parameters representing dose, intensity, and variability/pattern of activity were determined using MatLab.
Results— Minutes of activity and length of activity bouts significantly increased from predischarge to 6 weeks postdischarge (P=0.030).
Conclusions— The measurement of a variety of ambulatory activity parameters may aid clinicians and stroke survivors to determine whether exercise recommendations are being met with daily activity.
Key Words: stroke ambulatory activity activity recommendations
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Ambulatory Activity Data Collection
A step activity monitor (SAM; Cyma Corporation) was used to measure ambulatory activity. These monitors are valid for the measurement of ambulatory ability in people with stroke when walking on level surfaces, uneven surfaces, outdoors, and on stairs, as long as the monitor is positioned on the nonparetic leg.9 SAMs use a uniaxial accelerometer to determine number of strides per day, and intensity, variability, and pattern of activity can be calculated.
Ambulatory activity was monitored at each of 3 different time periods: predischarge (time 1), 2 weeks postdischarge (time 2), and 6 weeks postdischarge (time 3). Two days were monitored at time 1, and 3 days at each of time 2 and 3. Monitored days at time 1 were restricted to weekdays (full in-hospital days). Mean daily parameters are reported for each time period. Using the SAM software, the monitor was set to the participants height, typical walking speed (ie, slow, normal, fast), and leg motion (ie, dynamic/fidgety, normal, gentle/geriatric). The settings on the SAM were the same at all 3 time periods. Participants wore the SAM on the ankle of the nonparetic leg. Participants were instructed to wear the SAM from the time of rising in the morning until the time they went to bed at night, excluding time spent bathing or participating in water activities. Oral and written instructions were provided regarding proper SAM placement and wearing schedule.
Data Analysis
SAM data were downloaded via USB port. Each output file contained the number of strides in each of the 1440 minutes in a day (midnight to midnight). An algorithm was written using MatLab to allow calculation of parameters related to absolute activity, intensity of activity, variability, and pattern of activity (see Table 1 for list). Absolute activity was represented as the number of steps walked per day (summation of number of strides in each active minute with a stride count >1, multiplied by 2), absolute minutes of activity per day (total number of 1-minute intervals with stride count >1), and absolute number of activity bouts. Activity bouts were a defined event when the participant switched from inactivity (stride count
1 per minute) to activity (stride count >1 per minute), and ended when they returned to inactivity. Intensity of activity was characterized as the number of active minutes within defined parameters divided by the total number of active minutes (minutes with stride count >1), and expressed as a percentage. Low intensity activity parameters were active minutes with <15 strides, moderate activity as active minutes with
15 and <40 strides, and high activity as active minutes with
40 strides. Coefficient of variation (calculated as dispersion of 1-minute stride counts greater than 1 and expressed as coefficient of variation, 100x standard deviation/mean)5 and length of activity bouts represent variability and pattern of activity. Length of activity bouts were the number of consecutive minutes with stride counts >1 in each defined activity bout. Time monitored (total time in the day the monitor was worn) was calculated as the time from the first active minute to the last active minute over a 24-hour period. In all analysis, we chose to label minutes in which there was only one stride as inactive minutes. Accelerometer data provides support for this analysis decision as counts of less than 100 per minute10 were considered no activity. All ambulatory parameters demonstrated normal distributions and a repeated measures ANOVA was used to compare ambulatory activity outcomes across the 3 time periods.
|
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
No change over time in the number of steps per day differs from a previous study with stroke survivors where daily ambulatory activity improved from 2 weeks to 3 months postdischarge (1536 steps/per day to 2765 steps per day4). In addition, 2765 steps per day at 3 months postdischarge4 is on average half as many steps as our sample walked. These differences may seem surprising in light of similar motor FIM scores between samples, however Shaughnessy et al4 did not report time that the monitor was worn, our participants wore the monitor for 72 hours as opposed to 48 hours, and the time period between measurements was shorter in the current study (ie, less time for improvement). The difference in steps per day in the samples may in part reflect the variability seen in individuals poststroke, and the many factors that may contribute to activity poststroke.11 Recommended dose of activity in steps per day has been reported as 10 000 steps per day for people without disabilities and 3500 to 5500 steps per day for people with disabilities or chronic disease.12 However, the recommendation for people with disabilities has not been tested empirically. Future studies could examine associations between steps per day, metabolic outcomes, and functional outcomes in stroke survivors to more accurately provide recommendations.
Intensity of activity as measured by SAM has been reported by Michael and Macko6 in a sample of 79 community dwelling stroke survivors who walked on average 1389 steps per day. We used the same definition of low-intensity activity and found that 63% to 68% of activity was low-intensity activity in our sample, compared to the previous study where 45% of activity was low intensity.6 This finding indicates that although our participants took more steps, those additional steps were for the most part at a low intensity. It is unlikely that low-intensity stepping would fulfill activity recommendations2 for intensity of activity, though no studies to date have quantified energy expenditure (as a percent of peak oxygen uptake) of the various walking intensities recorded on the SAM. Another measurement option may be to calculate intensity of activity as a percent of peak activity (ie, the highest 1-minute stride count). Because of the varying levels of impairment in people with stroke, a relative measure of exercise intensity may be valuable. Studies with people with diabetes, who also tend to walk more slowly, have emphasized the potential importance of a relative measure of intensity in activity prescription.13
We report for the first time with stroke survivors variability and pattern of activity. Cavanaugh and colleagues suggest that older adults who demonstrate reduced variability of ambulatory activity "may not have as much capability to perform a range of ambulatory tasks under a variety of environmental conditions."5 It is possible that interventions that focus on increasing variability of ambulatory activity may lead to improvements in functional abilities. This question requires further study. CV did not demonstrate differences over time in our sample, and it may be a problematic outcome in instances where someone is consistently active without variation (results in a lower CV than someone who is less active but may have more spurts of activity throughout the day). It remains to be seen whether higher coefficients of variability (CVs) are desired, or whether a more useful outcome related to pattern of activity may be length of activity bouts.
Length of activity bouts increased by half a minute from time 1 to time 3 and may reflect increased capacity for activity, and a change in pattern of activity. Unlike absolute activity (measured in steps per day, minutes per day, or number of activity bouts), length of activity bouts is less affected by differential daily wearing time of the monitor. We do not know whether an increase in the length of activity bouts by half a minute is clinically significant. However, using our data for time 3, and a mean of 61 daily activity bouts, the increase in the length of activity bouts amounts to an extra 30 minutes of activity per day. As such length of activity bouts is an outcome that requires further study, as a potential target outcome for a walking intervention. A recent study with diabetic participants used accelerometry to measure breaks in sedentary time (ie, activity bouts), and found that more interruptions in sedentary time were associated with better metabolic outcomes.14 Activity-inactivity profiles can be provided by the SAM and may provide important avenues for new research.15
Summary
Our findings provide information about ambulatory outcomes reflecting dose, intensity, variability, and pattern of activity over time in a group of stroke survivors. The findings are limited by the small sample size and to a relatively healthy community dwelling group of stroke survivors. We provide suggestions for measurement of achievement of activity targets in stroke survivors which may be useful if interventions target activity behavior in addition or separate from aerobic and strength targets for exercise.
| Acknowledgments |
|---|
Sources of Funding
This study was funded by the Physiotherapy Foundation of Canada.
Disclosures
None.
Received July 21, 2008; accepted August 22, 2008.
| References |
|---|
|
|
|---|
2. Gordon NF, Gulanick M, Costa F, Fletcher G, Franklin BA, Roth EJ, Shephard T; American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Stroke. 2004; 35: 1230–1240.
3. Michael KM, Allen JK, Macko RF. Reduced ambulatory activity after stroke: the role of balance, gait, and cardiovascular fitness. Arch Phys Med Rehabil. 2005; 86: 1552–1556.[CrossRef][Medline] [Order article via Infotrieve]
4. Shaughnessy M, Michael KM, Sorkin JD, Macko RF. Steps after stroke: capturing ambulatory recovery. Stroke. 2005; 36: 1305–1307.
5. Cavanaugh JT, Coleman KL, Gaines JM, Laing L, Morey MC. Using step activity monitoring to characterize ambulatory activity in community-dwelling older adults. J Am Geriatr Soc. 2007; 55: 120–124.[Medline] [Order article via Infotrieve]
6. Michael KM, Macko RF. Ambulatory activity intensity profiles, fitness, and fatigue in chronic stroke. Top Stroke Rehabil. 2007; 14: 5–12.[CrossRef][Medline] [Order article via Infotrieve]
7. Gowland C, Stratford P, Ward M, Moreland J, Torresin W, Van Hullenaar S, Sanford J, Barreca S, Vanspall B, Plews N. Measuring physical impairment and disability with the Chedoke-McMaster Stroke Assessment. Stroke. 1993; 24: 58–63.
8. Stineman MG, Shea JA, Jette A, Tassoni CJ, Ottenbacher KJ, Fiedler R, Granger CV. The functional independence measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil. 1996; 77: 1101–1108.[CrossRef][Medline] [Order article via Infotrieve]
9. Mudge S, Stott NS, Walt SE. Criterion validity of the StepWatch Activity Monitor as a measure of walking activity in patients after stroke. Arch Phys Med Rehabil. 2007; 88: 1710–1715.[CrossRef][Medline] [Order article via Infotrieve]
10. Hagstromer M, Oja P, Sjostrom M. Physical activity and inactivity in an adult population assessed by accelerometry. Med Sci Sports Exerc. 2007; 39: 1502–1508.[CrossRef][Medline] [Order article via Infotrieve]
11. Resnick B, Michael K, Shaughnessy M, Nahm ES, Kobunek S, Sorkin J, Orwig D, Goldberg A, Macko RF. Inflated perceptions of physical activity after stroke: pairing self-report with physiologic measures. J Phys Act Health. 2008; 5: 308–318.[Medline] [Order article via Infotrieve]
12. Tudor-Locke CE, Myers AM. Methodological considerations for researchers and practitioners using pedometers to measure physical (ambulatory) activity. Res Q Exerc Sport. 2001; 72: 1–12.[Medline] [Order article via Infotrieve]
13. Johnson ST, Tudor-Locke C, McCargar LJ, Bell RC. Measuring habitual walking speed of people with type 2 diabetes: are they meeting recommendations? Diabetes Care. 2005; 28: 1503–1504.
14. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, Owen N. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care. 2008; 31: 661–666.
15. Esliger DW, Tremblay MS. Physical activity and inactivity profiling: the next generation. Can J Public Health. 2007; 98: S195–S207.[Medline] [Order article via Infotrieve]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |